At least 16 million Americans have a condition known as "pre-diabetes," where their blood sugar levels are higher than normal but not high enough to be diagnosed with diabetes. People with pre-diabetes are at risk of developing type 2 diabetes, a condition resulting from the body's inability to correctly use insulin.
As part of its efforts to learn more about pre-diabetes, the University of North Texas Health Science Center is seeking volunteers to participate in the largest clinical research trial studying the prevention of diabetes. The program spans 40 countries and will enroll more than 7,500 patients.
The clinical study will evaluate two medications currently approved for other uses by the Food and Drug Administration to determine whether they safely and effectively delay the onset of type 2 diabetes and reduce complications such as heart attack and stroke.If you have some of the following risk factors, you may qualify to participate:
Participants who qualify will receive study-related care, study medication, and diet and exercise counseling. For more information, call Enisa Arslanagic at 817-735-5159.
If you are with the media and need additional information or would like to arrange an interview,
please contact Jeff Carlton, Director of Media Relations, at 817-735-7630.